DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Andalib A, Rashed S, Dehbashi M, Hajati J, Noorbakhsh F, Ganjalikhani-Hakemi M.
The upregulation of hsa-mir-181b-1 and downregulation of its target CYLD in the
late-stage of tumor progression of breast cancer.
Indian Journal of Clinical Biochemistry 2020;
35: 312-321
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.